YDES YD Bio Limited Ordinary Shares
Healthcare$4.31-9.26%ClosedMarket Cap: $305.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-5.67
P/S
0.00
EV/EBITDA
-63.99
DCF Value
$0.12
FCF Yield
-0.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
80.8%
ROA
-37.5%
ROIC
-9.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY null | $596.8K | -7.1% | $-5.3M | $-8.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-389.2K | $-2.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-353.8K | $-3.4M | $— | — |
| Q4 null | $0.00 | NaN% | $-381.3K | $417.8K | $— | — |
| FY null | $510.4K | 30.4% | $-1.5M | $-1.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-260.1K | $2.2M | $— | — |
| Q2 null | $0.00 | NaN% | $-537.4K | $17.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.0M | $-22.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-506.7K | $692.0K | $— | — |
| FY null | $350.1K | 43.8% | $-9.8K | $13.6K | $— | — |
| FY null | $0.00 | NaN% | $-2.3M | $3.8M | $— | — |
| FY null | $0.00 | NaN% | $-1.7M | $8.7M | $— | — |